Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetr
about
Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III ranCombined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.[Effectiveness and cost of 5-HT3-antagonists in acute chemotherapy-induced emesis. Health-economic analysis based on current meta-analytic data]Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles. Ondansetron Study GroupComparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patientsInfluence of dosing times on cisplatin-induced peripheral neuropathy in rats.5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.5-Hydroxytryptamine3 receptor antagonists and cardiac side effects.Antiemetics in cancer chemotherapy: historical perspective and current state of the art.Comparative studies of various antiemetic regimens.Ondansetron dosing in pediatric gastroenteritis: a prospective cohort, dose-response study.Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium.Safety of ondansetron loading doses in children with cancer.Randomized, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy.A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
P2860
Q28245881-56C98201-A7E3-4833-9F81-7EBF1A543449Q30992721-FA3CACFF-3AAE-4C0A-A3F8-49880E9930B7Q31031408-0F53BBBC-E6B2-4428-B92E-9B699CED08F7Q32108358-F82E2054-8AE3-4680-BB43-ACCA96B08357Q34346342-E591EFDE-C4C2-48AE-AF00-8DB878B38C47Q35964114-A7F6B745-96DE-477B-AF7B-D319C4855433Q36080616-2BF9BF48-12C6-4B3A-B4FD-916FBA50A3F8Q36081699-36EEAF4C-2E69-4CA4-A644-5CE7948D376FQ36146524-AB5B3971-AE72-4E7F-821A-F26338D38247Q36147082-0D3FCBE3-64D2-4AE9-9BDA-38F3965C12C6Q37783929-89F4AD26-4301-46AC-B6F2-770E03513C1DQ38246665-CC058056-B175-4236-AB14-96C6AA4B54B8Q40673130-68BBA697-60A1-4D21-AD5E-787781268C51Q41129840-340A4F53-D81A-4506-BE51-86AB9EE04D5CQ42844944-E3C6FB39-5775-4A5B-AD51-C27336C10E9DQ46927060-328ADBE4-B921-4155-90C8-14C6ABEB6279Q46947074-F28A2A8F-F3AE-4BEB-B117-3F46B71AF6E1Q53901789-45A99033-816B-4C11-9EEB-7AE56942D2E0Q54454976-DE3C5640-184D-4E5A-842C-12EC8B8B9050Q55005460-89271B61-B9AD-4965-93FB-4722B5F723D2
P2860
Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetr
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@ast
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@en
type
label
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@ast
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@en
prefLabel
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@ast
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@en
P2093
P2860
P356
P1476
Comparison of the anti-emetic ...... arallel group study. Ondansetr
@en
P2093
Christmann D
Kitchener H
Porteder H
Schuller J
Seynaeve C
Van Belle S
P2860
P2888
P304
P356
10.1038/BJC.1992.241
P407
P577
1992-07-01T00:00:00Z
P5875
P6179
1036236808